Recent breakthroughs in the field of diabetes treatment have introduced a new class of medications known as GLP-1 receptor agonists. These agents work by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that regulates blood sugar levels. Among the most notew